admin

Pipeline updates are highly awaited events in the pharma/biotech sector as they play an important role in deciding whether or not to invest in a particular company. These updates provide information on experimental drugs and at times give an insight into the commercial potential of the candidate once it is successfully developed and commercialized.

Roche (RHHBY – Analyst Report) specializes in cancer drugs. Immunotherapy has received a lot of attention in recent times as pharmaceuticals majors focus their research and development efforts on the same.

The three-story brick building at the corner of Main and Osborn streets in Cambridge, on the edge of Kendall Square and the MIT campus, captures three distinct eras in the city’s innovation history. In the early 1800s, it was the site of Kimball & Davenport, the first builder of passenger railroad cars in America.

After World War II, it was the epicenter of the Massachusetts tech boom, home to the office and private lab of Edwin Land, Polaroid’s founder. In between, Thomas A. Watson strung a wire from Boston to Cambridge, and set up the equipment to receive the first “long distance” phone call, in 1876.

Lecture 1: The Importance of Commercializing Research Tuesday, October 7, 2014, 1:00 to 2:30 pm ET

Now on its seventh run, the Research Commercialization Introductory Course is a very popular online course designed to help science and engineering researchers better understand how research commercialization works. Over 5000 students, faculty and researchers from across the US have taken this course since it’s been offered.

Research commercialization involves taking articles, documentation, know-how, patents, and copyrights, which are created during research activities and getting them to users and patients for real societal impacts. In some cases, commercialization involved taking patents based on the research and licensing them to a company. This usually involves also having the researchers consult to the company. In other cases, commercialization involves forming of creating a startup and applying to federally funded commercialization programs. In all cases, though, research commercialization typically involves defining the nature of the research being commercialized (e.g., in a patent or intellectual property agreement), establishing a commercial relationship with another party (e.g., employment, a sale or license), and negotiating a contract (e.g., compensation).

Areas covered in the course include intellectual property, patents, copyrights, trade secrets, trademarks, licensing agreements, employment agreements, consulting agreements, tech transfer, creating and funding companies, and federally funded Small Business Innovation Research (SBIR) programs

Each lecture is a live 90-minute online class with Q&A.

Tasly Pharmaceuticals, Inc. made its official debut at the Natural Products Expo East 2014, held from September 17-20, 2014 in Baltimore, MD. As the leading East Cost trade show in the natural, healthy and organic products industry, attracting 22,000 professionals and representing 33% of the natural products industry, Expo East 2014 was a perfect opportunity for Tasly to introduce Deepure, its inaugural line of nutraceuticals. The line includes three condition-specific, whole-food and herb-based formulas, namely, ProHeart PLUS, ImmunoPower PLUS, and Re-Memory PLUS. All Deepure nutraceuticals are gluten-free and made without chemicals, preservatives, artificial colors, flavors, sweeteners, or gelatin. Deepure will be available in stores nationwide later this Fall.

Tasly also participated in two very attractive marketing and sponsorship opportunities located in New Products Pavilion, including Best of East Press Showcase and New Products Showcase.

The U.S. Commerce Department’s National Institute of Standards and Technology (NIST) has selected The MITRE Corporation to operate the first federally funded research and development center (FFRDC) solely dedicated to enhancing cybersecurity and protecting national information systems. MITRE will partner with the University System of Maryland (USM) to support the center.

The new FFRDC will support the National Cybersecurity Center of Excellence (NCCoE), which NIST, the state of Maryland, and Montgomery County, Md., established in 2012 to help businesses secure their data and digital infrastructure by bringing together information security experts from industry, government and academia. MITRE will further the NCCoE’s goal to foster public-private collaborations to identify and solve today’s most pressing cybersecurity challenges. Working with the University of Maryland, College Park (UMCP) and the University of Maryland, Baltimore County (UMBC), two leading research institutions within the USM, MITRE will carry out the goals of the new FFRDC in research, development, engineering and technical support as well as operations and facilities planning.

In the U.S., North America, and around the Globe, education innovation clusters are popping up across the landscape to solve the 21st century’s toughest learning challenges. Some of these economic development clusters, moreover entrepreneurship hubs, will lead in ways that others cannot. Maryland is one of them.

New research by scientists at the University of Maryland School of Medicine (UM SOM) and the Ottawa Heart Institute has uncovered a new pathway by which the brain uses an unusual steroid to control blood pressure. The study, which also suggests new approaches for treating high blood pressure and heart failure, appears today in the journal Public Library of Science (PLOS) One.

“This research gives us an entirely new way of understanding how the brain and the cardiovascular system work together,” said Dr. John Hamlyn, professor of physiology at the University of Maryland School of Medicine, one of the principal authors. “It opens a new and exciting way for us to work on innovative treatment approaches that could one day help patients.”

If you think the term “government invention” is an oxymoron—well, think again. You may be surprised to learn that many of the breakthrough technologies that shape our lives today are the brainchildren of government researchers—including those at FDA.

Alice WelchTake the Internet and that GPS in your car or on your cell phone. Both technologies were developed by the U.S. Department of Defense —as were the turbine engines that power the wind farms generating some 6% of our nation’s electrical energy. Those long-lasting radial tires on your vehicle? They’re reinforced with a material five times tougher than steel that was developed by a NASA partnership. And you can thank the government for your flu shot and the development of many other life-saving vaccines such as those for hepatitis A and B and HPV.

The cash keeps flowing in digital health.

Venture funding invested into the digital health realm has surpassed $3 billion through the first three quarters of 2014, up from $2 billion through midyear and up 100 percent over the year, according to the latest report from Rock Health.

New information technologies and innovative business models are transforming the health care industry in several ways. The industry is beginning to focus on creating seamless interoperability among organizations, greater efficiencies in the delivery of care and increased consumer engagement through access to electronic health records and use of mobile health devices and apps. “While creating forward movement and excitement in the industry, the very innovations that are driving growth and system improvement may also expose organizations to potentially more threats to security and privacy,” says Russ Rudish, Global Health Care Leader, Deloitte Touche Tohmatsu Limited.